Annual EQA Programme

Labquality’s external quality assessment programme (EQAS) is aimed at medical laboratories and point of care testing sites. The programme includes more than 170 clinically relevant external quality assessment schemes and it is fully compliant with ISO15189 standard requirements.

 

New SARS-CoV-2 EQA scheme is available. Register now!

 

Changes in the 2020 programme

New schemes and products

• • 2703 Anti-Müllerian hormone (tumour markers program)
    
  • 2749 Faecal occult blood, quantitative
    
  • 5304 Gastrointestinal viral multiplex
    
  • 7806 Preanalytics in anatomic pathology
    
  • 4330 Activated partial tromboplastin time, INR and fibrinogen (New parameter: INR)
  • 4340 / INR, LabPad, POCT
  • 5676 SARS-CoV-2, nucleic acid detection
  • 5677 SARS-CoV-2, antibody detection

Special programs by Noklus

• • 3501 Flagger program (Noklus)
  • 3500 Percentiler program (Noklus)

More information available on Noklus´website

Discontinued schemes and products

• • 4391 Anticoagulants: Rivaroxaban
  • 4339 INR, CoagSense, POCT (combined with product 4338)
  • 2221 Down´s syndrome screening, quality assurance
  • 8610 Veterinary basic blood count
  • 8530 Veterinary basic chemistry

All changes are listed in the Product Cataloque 2020 on page 5. Please download the catalogue from the link below.